11-50 Employees
Gelesis Funding
$0
66 rounds
Gelesis is active in the following markets / industries: biotechnology. The company has secured funding across 6 rounds and is valued at $0. Their most recent funding was raised on December 21, 2015.
Funding Rounds
B
$31500000U
$22000000U
$12000000
U
$2600000U
$3600000A
$16000000Investors of Gelesis
QIC BioVentures
Invesco
PureTech Health
PureTech Health is a biotech company dedicated to fighting diseases
Rounds
U
Invesco Asset Management
Rounds
B
Neomed Management
Legend Capital
Edmond de Rothschild Investment Partners
Angel investor in biotech companies. Exits include Exos, Rifiniti, PIKA Energy, Poly6, Endra, Videolicious, Streamroot, QuadWrangle and doDoc